share_log

We Think Shandong Wit Dyne HealthLtd's (SZSE:000915) Profit Is Only A Baseline For What They Can Achieve

We Think Shandong Wit Dyne HealthLtd's (SZSE:000915) Profit Is Only A Baseline For What They Can Achieve

我們認爲山東威特達因健康有限公司(SZSE: 000915)的利潤只是他們所能實現的目標的基準
Simply Wall St ·  03/22 19:51

Shandong Wit Dyne Health Co.,Ltd.'s (SZSE:000915) strong earnings report was rewarded with a positive stock price move. We have done some analysis, and we found several positive factors beyond the profit numbers.

山東威特達因健康有限公司, Ltd. 's(深圳證券交易所股票代碼:000915)強勁的收益報告獲得了股價的積極走勢的回報。我們做了一些分析,除了利潤數字外,我們還發現了幾個積極因素。

earnings-and-revenue-history
SZSE:000915 Earnings and Revenue History March 22nd 2024
SZSE: 000915 收益和收入歷史記錄 2024 年 3 月 22 日

A Closer Look At Shandong Wit Dyne HealthLtd's Earnings

仔細看看山東威特達因健康有限公司的收益

One key financial ratio used to measure how well a company converts its profit to free cash flow (FCF) is the accrual ratio. The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. You could think of the accrual ratio from cashflow as the 'non-FCF profit ratio'.

用於衡量公司將其利潤轉換爲自由現金流(FCF)的情況的一個關鍵財務比率是應計比率。應計比率從給定時期的利潤中減去FCF,然後將結果除以該時間內公司的平均運營資產。你可以將現金流的應計比率視爲 “非FCF利潤率”。

That means a negative accrual ratio is a good thing, because it shows that the company is bringing in more free cash flow than its profit would suggest. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future".

這意味着負應計比率是一件好事,因爲它表明該公司帶來的自由現金流超出了其利潤所暗示的範圍。這並不意味着我們應該擔心應計比率爲正,但值得注意的是,應計比率相當高的地方。引用Lewellen和Resutek在2014年發表的一篇論文,“應計額較高的公司未來的利潤往往會降低”。

Shandong Wit Dyne HealthLtd has an accrual ratio of -0.43 for the year to December 2023. That implies it has very good cash conversion, and that its earnings in the last year actually significantly understate its free cash flow. To wit, it produced free cash flow of CN¥1.1b during the period, dwarfing its reported profit of CN¥585.3m. Over the last year, Shandong Wit Dyne HealthLtd's free cash flow remained steady.

截至2023年12月的一年中,山東威特達因健康有限公司的應計比率爲-0.43。這意味着它的現金轉化率非常好,而且其去年的收益實際上大大低估了其自由現金流。換句話說,它在此期間產生了11億元人民幣的自由現金流,使其報告的5.853億元利潤相形見絀。去年,山東威特達因健康有限公司的自由現金流保持穩定。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Shandong Wit Dyne HealthLtd's Profit Performance

我們對山東威特達因健康有限公司盈利表現的看法

Happily for shareholders, Shandong Wit Dyne HealthLtd produced plenty of free cash flow to back up its statutory profit numbers. Because of this, we think Shandong Wit Dyne HealthLtd's underlying earnings potential is as good as, or possibly even better, than the statutory profit makes it seem! And on top of that, its earnings per share have grown at an extremely impressive rate over the last three years. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. Obviously, we love to consider the historical data to inform our opinion of a company. But it can be really valuable to consider what other analysts are forecasting. Luckily, you can check out what analysts are forecasting by clicking here.

令股東高興的是,山東威特達因健康有限公司產生了充足的自由現金流來支持其法定利潤數字。因此,我們認爲Shandong Wit Dyne HealthLtd的基礎盈利潛力與法定利潤看上去一樣好,甚至可能更好!最重要的是,在過去三年中,其每股收益以極其驚人的速度增長。歸根結底,如果你想正確地了解公司,必須考慮的不僅僅是上述因素。顯然,我們喜歡考慮歷史數據來爲我們對公司的看法提供依據。但是,考慮其他分析師的預測可能非常有價值。幸運的是,您可以點擊此處查看分析師的預測。

Today we've zoomed in on a single data point to better understand the nature of Shandong Wit Dyne HealthLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我們放大了單一數據點,以更好地了解山東威特達因健康有限公司利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。例如,許多人認爲高股本回報率是有利的商業經濟的標誌,而另一些人則喜歡 “關注資金”,尋找內部人士正在買入的股票。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論